Key Business Highlights:
- In
October 2021 we completed the merger withSprings Rejuvenation, LLC , aStem Cell and Anti-Aging Treatment Company - In
January 2022 we purchased two C-arm, high definition 3D imaging for direct visualization of the injection point. These are primarily used to service the back pain market. - On
January 24, 2022 we entered into a lease for a new clinic location inFt. Lauderdale, FL. - On
January 27, 2022 we entered into a partnership with DrAnn Shippy who operates a clinic inAustin TX . After training Ann and her staff, we began performing procedures there this month. - In
February 2022 we announced a +200% increase in 4th quarter earnings compared to the 3rd quarter. We nearly matched the earnings of the previous 3 quarters, pre merger, with the last quarter earnings. - In
March 2022 we moved into a new clinic location in the Perimeter Center area ofAtlanta . This clinic is now seeing patients. - On
March 9, 2022 we opened our previously announced clinic inFt Lauderdale, FL. - On
March 9, 2022 we completed the processes required to change the name and ticker symbol toSprings Rejuvenation, Inc. (SPRJ) - On
March 15, 2022 we partnered with American Top Team, by providing stem cell therapies and treatments to their members and competitive athletes.
“We believe in the short time since
About
At
For additional information visit www.springsrejuvenation.com
FORWARD-LOOKING STATEMENTS:
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Investor Relations Contact
516-662-9461 / andrew@barwicki.com
Company Twitter: @Springsavra
Source:
2022 GlobeNewswire, Inc., source